IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So, it is now announced that public requests, orders, notifications and directives (except for easing restrictions) released by Union-Level Organizations and Union Ministries up to 30 April 2024 have been extended to 31 May 2024 for prevention, control and treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So it
is now announced that public requests, orders, notifications and directives (except for easing
restrictions) released by Union-Level Organizations and Union Ministries up to 31 March 2024
have been extended to 30 April 2024 for prevention, control and treatment on Coronavirus
Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So
it is now announced that public requests, orders, notifications and directives (except for
easing restrictions) released by Union-Level Organizations and Union Ministries up to 29
February 2024 have been extended to 31 March 2024 for prevention, control and treatment
on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So, it is now announced that public requests, orders, notifications and directives (except for easing restrictions) released by Union-Level Organizations and Union Ministries up to 31 January 2024 have been extended
to 29 February 2024 for prevention, control and treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease (COVID-19) infection continuously. So, it is
now announced that public requests, orders, notifications and directives (except for easing
restrictions) released by Union-Level Organizations and Union Ministries up to 31 December 2023 have been extended to 31 January 2024 for prevention, control and treatment on
Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
It is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously.
So, it is now announced that public requests, orders, notifications and directives (except
for easing restrictions) released by Union-Level Organizations and Union Ministries up
to 30 November 2023 have been extended to 31 December 2023 for prevention, control and
treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So, it is now announced that public requests, orders, notifications and directives (except for easing restrictions) released by Union-Level Organizations and Union Ministries up to 31 October 2023 have been extended to 30 November 2023 for prevention, control and treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously. So, it is now announced that public requests, orders, notifications and directives except for easing restrictions released
by Union-Level Organizations and Union Ministries up to 30 September 2023 have been extended to 31
October 2023 for prevention, control and treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
IT is necessary to control Coronavirus Disease 2019 (COVID-19) infection continuously.
So, it is now announced that public requests, orders, notifications and directives except
for easing restrictions released by Union-level Organizations and Union Ministries up
to 31 August 2023 have been extended to 30 September 2023 for prevention, control and
treatment on Coronavirus Disease (COVID-19).
Source: The Global New Light of Myanmar
The State-owned pharmaceutical factory (Insein) (BPI) is poised to enhance its production of novel anti-COVID medications while continuing the freeze-drying of anti-snake venom in the upcoming year.
BPI has significantly expanded its pharmaceutical production network, encompassing branches like the pharmaceutical factories in Ywathagyi, Inyaung, PyinOoLwin, and Sagaing. Other components include the Anti-Snake Venom Production Branch in Hmawby, the Horse Ranches in Myitchay, Yanpel, and Heho, the Tatmadaw Pharmaceuticals Factory (Hmawby), and the Universities of Pharmacy in Yangon and Mandalay. These enclose the Pharmaceutical Factory (Insein) and the Research Unit.
Furthermore, BPI has inaugurated a modern freeze-dryer machine and unveiled the BPI Pharmaceutical Museum on 14 August, intending to bolster anti-snake venom production using the freeze-drying system in the coming years. The establishment of the BPI Pharmaceutical Museum aims to preserve over six decades of pharmaceutical production experience, equipment, methods, important medical literature, and the legacy of pharmaceutical manufacturing by a Myanmar State-owned enterprise.
The production of anti-snake venom has demonstrated a consistent increase. With 60,000 units manufactured last year, the figure has surged to 80,000 this year.
Source: The Global New Light of Myanmar